• Advertise
  • Donate
  • Subscribe
    • Become a print subscriber
    • Sign up for e-Newsletter
    • e-Editions
Wednesday, May 31, 2023
No Result
View All Result
Minnesota Spokesman-Recorder
  • News & Features
    • National
    • Local
    • Special Editions
      • MLK Legacy
      • Black History Month
      • The MSR Celebrates Women’s History Month
  • All Sections
    • Opinion
      • Mellaneous by Mel Reeves
      • Word on the Street
      • Reaching Out From Within
    • Health + Wellness
      • Minnesota Cancer Alliance Breast Cancer Gaps Project
    • Sports
      • Timberwolves/NBA
      • Lynx/WNBA
        • 20 in 20
      • Twins/MLB
      • MN Wild/NHL
      • Vikings/NFL
    • Business
      • Small Business Month Celebration
      • Black Business Spotlight
      • Finances FYI
    • Arts + Culture
    • Photo Galleries
    • MSR Forefront Digital Roundtable Series
      • MSR Forefront Highlights
    • Go Green
    • Education
    • Bulletin
    • Jobs & Opportunities
      • Legals
  • Events
    • Submit an event!
  • Obits
  • Sister Spokesman
  • e-Editions
Minnesota Spokesman-Recorder
  • News & Features
    • National
    • Local
    • Special Editions
      • MLK Legacy
      • Black History Month
      • The MSR Celebrates Women’s History Month
  • All Sections
    • Opinion
      • Mellaneous by Mel Reeves
      • Word on the Street
      • Reaching Out From Within
    • Health + Wellness
      • Minnesota Cancer Alliance Breast Cancer Gaps Project
    • Sports
      • Timberwolves/NBA
      • Lynx/WNBA
        • 20 in 20
      • Twins/MLB
      • MN Wild/NHL
      • Vikings/NFL
    • Business
      • Small Business Month Celebration
      • Black Business Spotlight
      • Finances FYI
    • Arts + Culture
    • Photo Galleries
    • MSR Forefront Digital Roundtable Series
      • MSR Forefront Highlights
    • Go Green
    • Education
    • Bulletin
    • Jobs & Opportunities
      • Legals
  • Events
    • Submit an event!
  • Obits
  • Sister Spokesman
  • e-Editions
No Result
View All Result
Minnesota Spokesman-Recorder
No Result
View All Result

FDA grants full approval to Pfizer vaccine

by MSR News Online
August 23, 2021
36
SHARES
720
VIEWS
Share on FacebookShare on LinkedIn
Pfizer vaccine
MGN

A major public health milestone was reached on Monday as the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The Pfizer-BioNTech vaccine has become the first vaccine to be approved by the FDA.

“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization (EUA), as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” Acting FDA Commissioner Janet Woodcock, M.D. said.

“While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.,” continued Woodcock.

Governor Tim Walz echoed Woodcock’s sentiment in a statement released Monday afternoon. “The FDA’s approval of Pfizer’s COVID-19 vaccine is exciting news. This vaccine is safe, it’s saving lives, and now it’s fully approved,” Walz said.

“Today’s action gives Minnesotans additional assurance that the Pfizer vaccine is safe and effective. Along with vaccines from Moderna and Johnson & Johnson, these are the best tools we have in our fight against COVID-19. If you haven’t yet, now is the time to roll up your sleeves and get your shot,” Walz said.

- ADVERTISEMENT -

Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021.

Now that the Pfizer-BioNTech vaccine has been approved by the FDA, it will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. 

Comirnaty (Pfizer vaccine) contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19. The result of a person receiving this vaccine is that their immune system will ultimately react defensively to the virus that causes COVID-19. The mRNA in Comirnaty is only present in the body for a short time and is not incorporated into – nor does it alter – an individual’s genetic material. Comirnaty has the same formulation as the EUA vaccine and is administered as a series of two doses, three weeks apart. 

FDA evaluation of safety and effectiveness data for approval for 16 years of age and older

To support the FDA’s approval decision, the FDA reviewed updated data from the clinical trial which supported the EUA and included a longer duration of follow-up in a larger clinical trial population. 

- ADVERTISEMENT -

Specifically, in the FDA’s review for approval, the agency analyzed effectiveness data from approximately 20,000 vaccine and 20,000 placebo recipients ages 16 and older who did not have evidence of the COVID-19 virus infection within a week of receiving the second dose. The safety of Comirnaty was evaluated in approximately 22,000 people who received the vaccine and 22,000 people who received a placebo 16 years of age and older.

Based on results from the FDA’s clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.  More than half of the clinical trial participants were followed for safety outcomes for at least four months after the second dose. Overall, approximately 12,000 recipients have been followed for at least 6 months.

Going forward, the FDA and Centers for Disease Control and Prevention (CDC) have monitoring systems in place to ensure that any safety concerns continue to be identified and evaluated in a timely manner.

Comirnaty (Pfizer vaccine) is now approved for Americans 16 years of age and older. The vaccine continues to be available to Americans between 12 and 15 years of age under an Emergency Use Authorization (EUA). Two other vaccines—the single-dose Johnson & Johnson vaccine and the two-dose Moderna vaccine—are authorized for Americans 18 years of age and older.

The FDA is continuing its review and approval process for these two vaccines as well as for use of Pfizer in people younger than 16.

- ADVERTISEMENT -

All COVID-19 vaccines are free, and readily available at hospitals, pharmacies, clinics, and other health care providers around Minnesota. Visit vaccines.gov to find a vaccine location near you and to sort by vaccine type.

Support Black local news

Help amplify Black voices by donating to the MSR. Your contribution enables critical coverage of issues affecting the community and empowers authentic storytelling.

Donate Now!

ADVERTISEMENT
Previous Post

Legal Free-For-All Rages Over Oil, Gas And Coal Leases On Federal Lands

Next Post

Enrollment increases at HBCUs

MSR News Online

Reach the MSR staff at msrnewsonline@spokesman-recorder.com.

You Might Also Like

Feds OK over-the-counter sale of overdose-reversing drug
Health & Wellness

Feds OK over-the-counter sale of overdose-reversing drug

New funding targets opioid prevention, treatment in communities of color
Local

New funding targets opioid prevention, treatment in communities of color

Experiencing hair loss? Don’t panic!
Health & Wellness

Experiencing hair loss? Don’t panic!

People with long Covid face barriers to government disability benefits
COVID-19

People with long Covid face barriers to government disability benefits

Long Covid: What is it?
COVID-19

Long Covid: What is it?

President Biden tests positive for COVID
National

President Biden tests positive for COVID

Next Post
Enrollment increases at HBCUs

Enrollment increases at HBCUs

  • Facebook
  • Instagram
  • Twitter
  • YouTube
ADVERTISEMENT

The Latest News

Bees can learn, remember, think and make decisions

Bees can learn, remember, think and make decisions

Black woman shopping for produce

The impact of food insecurity on Black women’s mental health

Plenty of action at St. Paul City Conference track and field meet

Plenty of action at St. Paul City Conference track and field meet

 Lynx rookie forward finds much to learn

 Lynx rookie forward finds much to learn

Call of the wild: Hunting for edible mushrooms is not just a White man’s hobby 

Call of the wild: Hunting for edible mushrooms is not just a White man’s hobby 

One Minnesota’s transformative budget

One Minnesota’s transformative budget

Minneapolis
◉
88°
Fair
5:30 am8:51 pm CDT
ThuFriSatSunMon
90/68°F
86/66°F
88/68°F
90/66°F
91/66°F
Weather forecast Minneapolis, Minnesota ▸
ADVERTISEMENT
ADVERTISEMENT

Upcoming Events

Apr 6
April 6 @ 7:30 pm-June 3 @ 9:00 pm Recurring

Wit by Margaret Edson

Apr 14
April 14 @ 9:00 am-August 12 @ 5:00 pm

Paper Is People: Decolonizing Global Paper Cultures

May 31
10:00 am-4:00 pm Recurring

Preserving Nature Photos by Walter Griffin: REFLECTIONS

Jun 1
5:00 pm-7:00 pm

Metro State University one 1 Open House

View Calendar

Read our latest e-Edition!

ADVERTISEMENT
ADVERTISEMENT

Subscribe

  • Home/Office Delivery
  • Weekly e-newsletter
  • e-Editions

Support

  • Donate
  • Subscribe
  • MSR Newsstand Locations

Connect

  • About
    • MSR Staff
  • Contact
  • Send a news tip
  • About
  • Privacy Policy
  • Terms

© 2023 Minnesota Spokesman-Recorder

No Result
View All Result
  • News & Features
    • Local
    • National
  • All Sections
    • Arts & Culture
    • Health & Wellness
      • MN Cancer Alliance Breast Cancer Gaps Project
    • Business
      • Black Business Spotlight
      • Finances FYI
      • Small Business Month Celebration
    • Opinion
    • Sports
  • Events
  • Obits
  • Sister Spokesman
  • Donate
  • Subscribe

© 2023 Minnesota Spokesman-Recorder

 

Loading Comments...